News of the US CRDC granting funds to do testing on Immunoxel came out in April (as far as I know). We can be sure Ekomed will be on the go with this testing. Combining that with the fact South Africas' Health Department has allowed it to be used is interesting in that the claimed results can be tested 'in the field'. If Immunoxel is effective, then patient response and turnaround (as in return to health and less time in terms of hospital stays) will mean great savings for hospitals.
As I said before, this might be very interesting; but who knows in this game.
technical analysis shows key reversal, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)